NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. (“Lev”) (OTCBB: LEVP) today announced financial results for the three months ended March 31, 2008. Lev will conduct a conference call and audio webcast at 8:30 a.m. Eastern Time (ET) on Monday morning, May 5, 2008 to discuss its financial results and to provide an update on its lead product candidate, Cinryze™ (C1 inhibitor). The call will be webcast live and may be accessed by visiting the company’s website at www.levpharma.com. A replay will be available for a limited time following the live call.
